Skip to main content
Veterinary Medicines

BioBos L(6), Injekční suspenze

Authorised
  • Leptospira interrogans, Serogroup Pomona, Inactivated
  • Leptospira interrogans, serogroup Sejroe, serovar Hardjo-prajitno, Inactivated
  • Leptospira interrogans, serogroup Sejroe, serovar Hardjo-bovis, Inactivated
  • Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, Inactivated

Product identification

Medicine name:
BioBos L(6), Injekční suspenze
Active substance:
  • Leptospira interrogans, Serogroup Pomona, Inactivated
  • Leptospira interrogans, serogroup Sejroe, serovar Hardjo-prajitno, Inactivated
  • Leptospira interrogans, serogroup Sejroe, serovar Hardjo-bovis, Inactivated
  • Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, Inactivated
Target species:
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, Serogroup Pomona, Inactivated
    16.00
    unit(s)
    /
    1.00
    Dose
  • Leptospira interrogans, serogroup Sejroe, serovar Hardjo-prajitno, Inactivated
    35.00
    unit(s)
    /
    1.00
    Dose
  • Leptospira interrogans, serogroup Sejroe, serovar Hardjo-bovis, Inactivated
    32.00
    unit(s)
    /
    1.00
    Dose
  • Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, Inactivated
    64.00
    unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat
        0
        day
      • Milk
        0
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB03
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicines
Authorisation number:
  • 96/021/11-C
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."